Medicare Compliance & Reimbursement - 2003 Issue 41
Medicare Reform: LEGISLATORS STILL DISAGREE ON ROLE OF PRIVATE PLANS
Subscribe or sign in to view the full article.
Article Overview
This article covers late-stage Medicare reform negotiations and the policy disputes still being worked out by congressional conferees. It focuses on the structure of the drug benefit, the treatment of private plans such as PPOs in regional and county-based markets, benchmark and payment concerns, rural access incentives, and the role of CMS, AAHP, and other federal and industry voices in shaping the outcome. It is relevant to readers tracking Medicare policy, managed care, and reimbursement-related legislative changes.
Why This Topic Matters
The article matters because it summarizes Medicare reform issues that could affect plan participation, beneficiary drug coverage structure, and future payment policy. It also highlights how federal agencies, lawmakers, and health plan groups are debating incentives, market structure, and funding approaches.
Article Sections
-
Drug benefit structure under negotiation
Summarizes the broad framework under discussion for Medicare drug coverage and beneficiary cost-sharing. It notes that the parties were still negotiating final details at the time of the article.
-
Can Local and Regional PPOs Coexist?
Covers the debate over how private plans would participate in county-based and regional Medicare structures. It discusses differing House and Senate approaches, CMS commentary, and questions about region size and plan incentives.
-
Do Plans Need More Money Than FFS?
Addresses disputes over whether private plans would need additional payment support compared with traditional Medicare-based benchmarks. It also discusses antitrust concerns, rural access, blended benchmark ideas, and possible extra payments for certain areas.
What You Will Learn
- How Medicare reform negotiators were structuring the drug benefit framework
- What issues were being debated about private plan participation in Medicare
- Why payment benchmarks and plan compensation were controversial
- How rural access and market competition concerns affected the discussion
- Which organizations and federal officials were involved in the policy debate
Who Should Read This
- Medical coders and revenue cycle professionals tracking Medicare policy
- Healthcare administrators and compliance staff
- Managed care and payer policy analysts
- Physician practice managers
- Health policy researchers and journalists
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com